Statement of Retraction: Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome
Saved in:
Format: | Book |
---|---|
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statement of Retraction: Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome
Published: (2024) -
Statement of Retraction: Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial
Published: (2024) -
Statement of Retraction: Luteal support with vaginal dydrogesterone increases pregnancy rate in patients with clomifene resistant polycystic ovary syndrome receiving letrozole for ovulation induction
Published: (2024) -
Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome
by: Yazed Sulaiman Al-Ruthia, et al.
Published: (2017) -
Statement of Retraction: Can Metformin reduce the incidence of Gestational Diabetes Mellitus in pregnant women with polycystic ovary syndrome? Prospective Cohort Study
Published: (2024)